Published in Mayo Clin Proc on July 01, 1999
Male sexual dysfunction and infertility associated with neurological disorders. Asian J Androl (2011) 1.01
Extending the rationale of combination therapy to unresponsive erectile dysfunction. Rev Urol (2007) 0.80
Estrogen-induced maldevelopment of the penis involves down-regulation of myosin heavy chain 11 (MYH11) expression, a biomarker for smooth muscle cell differentiation. Biol Reprod (2012) 0.80
Neurogenic erectile dysfunction. Clin Auton Res (2001) 0.77
The impact of diabetes mellitus on penile length in men undergoing inflatable penile prosthesis implantation. Turk J Urol (2013) 0.75
Identification of a nuclear localization signal of a yeast ribosomal protein. Proc Natl Acad Sci U S A (1985) 2.39
Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol (1994) 2.10
Percutaneous removal of kidney stones: review of 1,000 cases. J Urol (1985) 2.04
Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol (1994) 1.75
Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1. J Virol (1991) 1.70
Mayo Clinic long-term analysis of the functional durability of the AMS 800 artificial urinary sphincter: a review of 323 cases. J Urol (1998) 1.66
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci (2006) 1.52
High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol (2000) 1.44
Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology (1999) 1.42
Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Urology (1996) 1.42
Long-term followup and evaluation of primary realignment of posterior urethral disruptions. J Urol (1997) 1.40
Visual laser ablation of the prostate: a preliminary report. Mayo Clin Proc (1995) 1.40
Expression of the polyomavirus VP2 and VP3 proteins in insect cells: coexpression with the major capsid protein VP1 alters VP2/VP3 subcellular localization. Virology (1993) 1.32
High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology (1998) 1.28
Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol (1995) 1.28
Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure. J Urol (1996) 1.24
Comparison of techniques for vesicourethral anastomosis: simple direct versus modified Vest traction sutures. Urology (1988) 1.13
Acute panautonomic neuropathy. Ann Neurol (1983) 1.11
High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology (1997) 1.06
Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology (1996) 1.04
Natural history of prostatism: urinary flow rates in a community-based study. J Urol (1993) 1.04
Colorimetric method for the determination of lipoxygenase activity. J Agric Food Chem (2001) 1.02
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology (1996) 1.01
Improvement of pressure flow parameters with finasteride is greater in men with large prostates. Finasteride Urodynamics Study Group. J Urol (1999) 1.01
Artificial urinary sphincter cuff erosion. Experience with reimplantation in 38 patients. Urology (1990) 1.00
Engineering analysis of penile hemodynamic and structural-dynamic relationships: Part I--Clinical implications of penile tissue mechanical properties. Int J Impot Res (1998) 0.99
Engineering analysis of penile hemodynamic and structural-dynamic relationships: Part II--Clinical implications of penile buckling. Int J Impot Res (1998) 0.99
Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen receptor-negative human breast cancer. Diagn Mol Pathol (1997) 0.97
Giant leiomyoma of the prostate. Arch Pathol Lab Med (1987) 0.96
Repeated pressure-flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement. Finasteride Urodynamics Study Group. Neurourol Urodyn (1999) 0.95
Success of de novo reimplantation of the artificial genitourinary sphincter. J Urol (2000) 0.94
Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res (2002) 0.93
Percutaneous removal of kidney stones. Preliminary report. Mayo Clin Proc (1982) 0.92
Possible role of Na(+)-K(+)-ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide. Br J Pharmacol (1995) 0.92
The artificial urinary sphincter in the female: indications for use, surgical approach and results. Int Urogynecol J Pelvic Floor Dysfunct (1998) 0.92
Stented versus nonstented ureteroileal anastomoses: is there a difference with regard to leak and stricture? J Urol (1985) 0.91
Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy. J Urol (1987) 0.91
Flow evaluation and simultaneous external sphincter electromyography in clinical urodynamics. J Urol (1981) 0.91
Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors. Cancer (1992) 0.91
Observations on vesical diverticulum in childhood. J Urol (1976) 0.90
Artificial urethral sphincter for incontinence. Urology (2000) 0.90
Recurrent or persistent urinary incontinence in patients with the artificial urinary sphincter: diagnostic considerations and management. J Urol (1985) 0.89
Immunodetection of nmt55/p54nrb isoforms in human breast cancer. BMC Cancer (2001) 0.89
The model AS 800 artificial urinary sphincter: Mayo Clinic experience. J Urol (1987) 0.89
Endothelin in the urinary bladder. I. Synthesis of endothelin-1 by epithelia, muscle and fibroblasts suggests autocrine and paracrine cellular regulation. J Urol (1992) 0.88
The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study. J Urol (1981) 0.87
Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction. Int J Impot Res (2002) 0.87
An implantable mechanical urinary sphincter: a new nonhydraulic design concept. Urology (1998) 0.86
Mayo Clinic experience with use of the AMS800 artificial urinary sphincter for urinary incontinence following radical prostatectomy. J Urol (1989) 0.86
Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells. Mol Cell Biol Res Commun (2000) 0.86
Use of the artificial urinary sphincter in the management of severe incontinence in females. Surg Gynecol Obstet (1985) 0.86
Prostanoid production in rabbit corpus cavernosum: I. regulation by oxygen tension. J Urol (1996) 0.85
Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol (1998) 0.85
The management of severe urinary incontinence in patients with myelodysplasia by implantation of the AS 791/792 urinary sphincter device. J Urol (1982) 0.85
Primary realignment of posterior urethral injuries. J Urol (1983) 0.85
Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Commun (1998) 0.85
Mayo Clinic experience with the AS800 artificial urinary sphincter for urinary incontinence after transurethral resection of prostate or open prostatectomy. Urology (1993) 0.85
Postprostatectomy urinary incontinence: a comparison of the cost of conservative versus surgical management. Urology (1998) 0.85
Low-density lipoprotein antioxidant activity of phenolic compounds and polyphenol oxidase activity in selected clingstone peach cultivars. J Agric Food Chem (2000) 0.85
Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1. Int J Impot Res (2002) 0.85
Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. Am J Physiol Cell Physiol (2001) 0.84
Use of the artificial urinary sphincter in men and women. World J Urol (1997) 0.84
Neurologic erectile dysfunction. Urol Clin North Am (2001) 0.84
Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist. Br J Pharmacol (2006) 0.83
Success of the narrow-backed cuff design of the AMS800 artificial urinary sphincter: analysis of 144 patients. J Urol (1993) 0.83
Role of alpha adrenergic receptors in erectile function. Int J Impot Res (2000) 0.83
Transforming growth factor-beta1 (TGF-beta1) is sufficient to induce fibrosis of rabbit corpus cavernosum in vivo. J Urol (1999) 0.83
The Jonas prosthesis--technical considerations and results. J Urol (1983) 0.83
Incontinence, intermittent self-catheterization and the artificial genitourinary sphincter. J Urol (1984) 0.82
Evaluation of psychogenic urinary retention. J Urol (1978) 0.82
Engineering analysis of penile hemodynamic and structural-dynamic relationships: Part III--Clinical considerations of penile hemodynamic and rigidity erectile responses. Int J Impot Res (1998) 0.82
G-protein-coupled receptor agonists augment adenylyl cyclase activity induced by forskolin in human corpus cavernosum smooth muscle cells. Recept Signal Transduct (1997) 0.82
Combined implantation of artificial sphincter and penile prosthesis. J Urol (1989) 0.81
Cyclic AMP regulates mRNA expression of alpha-1d and alpha-2a adrenergic receptors in cultured human corpus cavernosum smooth muscle cells. Int J Impot Res (2000) 0.81
Identification of alpha 1-adrenergic receptor subtypes in human corpus cavernosum tissue and in cultured trabecular smooth muscle cells. Receptor (1995) 0.81
Expression of functional muscarinic acetylcholine receptor subtypes in human corpus cavernosum and in cultured smooth muscle cells. Receptor (1995) 0.81
Prosthetic bladder augmentation and replacement. Semin Urol (1984) 0.80
Patient and partner satisfaction with the AMS 700 penile prosthesis. J Urol (1992) 0.80
Radical prostatectomy incontinence and the AS791 artificial urinary sphincter. J Urol (1983) 0.80
Development of human and rabbit vaginal smooth muscle cell cultures: effects of vasoactive agents on intracellular levels of cyclic nucleotides. Mol Cell Biol Res Commun (1999) 0.80
High-power potassium titanyl phosphate laser vaporization prostatectomy. Mayo Clin Proc (1998) 0.79
Transurethral enzymatic ablation of the prostate: canine model. Urology (1996) 0.79
Synthesis and characterization of N-(4-azidophenylthio)phthalimide: A cleavable, photoactivable crosslinking reagent that reacts with sulfhydryl groups. Anal Biochem (1982) 0.79
Corporeal structural and vascular micro architecture with X-ray micro computerized tomography in normal and diabetic rabbits: histopathological correlation. J Urol (2001) 0.79
Primary lymphoma of prostate: transrectal ultrasonic appearance. Urology (1990) 0.79
Does nocturnal deactivation of the artificial urinary sphincter lessen the risk of urethral atrophy? Urology (2001) 0.79
Anastomotic obstruction after stapled enteroanastomosis. Surgery (1991) 0.79
Urothelial substitutes: bladder. J Endourol (1993) 0.78
Preliminary report on the development and characterization of rabbit clitoral smooth muscle cell culture. Int J Impot Res (1998) 0.78
Rectal injury occurring at radical retropubic prostatectomy for prostate cancer: etiology and treatment. Urology (1993) 0.78
Stimulation of collagen production in an in vitro model for Peyronie's disease. Int J Impot Res (2000) 0.78
Laser prostatectomy: two and a half years' experience with aggressive multifocal therapy. Urology (1996) 0.78
Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia. Cancer (1991) 0.78
The expression of functional postsynaptic alpha2-adrenoceptors in the corpus cavernosum smooth muscle. Br J Pharmacol (1998) 0.78
Interaction of the "back" of yeast iso-1-cytochrome C with yeast cytochrome C oxidase. Biochem Biophys Res Commun (1981) 0.78
A new temporary catheter (ContiCath) for the treatment of temporary, reversible, postoperative urinary retention. Urology (1999) 0.78
Realities of diagnosing Helicobacter pylori infection in clinical practice: a case for non-invasive indirect methodologies. Yale J Biol Med (1999) 0.78